HIVHep Profile Banner
HIV+Hepatitis Policy Institute Profile
HIV+Hepatitis Policy Institute

@HIVHep

Followers
2K
Following
3K
Media
4K
Statuses
9K

Led by Carl Schmid, promotes quality & affordable healthcare for people living w/ or at risk of HIV, hepatitis, or other serious and chronic health conditions

Washington, DC
Joined December 2019
Don't wanna be here? Send us removal request.
@HIVHep
HIV+Hepatitis Policy Institute
5 hours
A handful of vertically integrated PBMs now control prescription drug access for most Americans. This level of consolidation demands oversight. The Senate Finance Committee hearing on Nov. 19 is an important step. #PBMReform @RonWyden @MikeCrapo https://t.co/WOWSywaXmY
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
1 day
PBM-affiliated pharmacies have marked up some so-called specialty generics by more than 1,000 percent. @SenateFinance / @SenFinance must address how these middleman #PBMs raise drug costs and reduce access. #PBMreform @RonWyden @MikeCrapo https://t.co/WOWSywaXmY
0
1
1
@AutoimmuneAssoc
Autoimmune Association
1 day
While we wait for Congress to rein in the #PBMs, these middlemen cook up new schemes to game the system. We cannot delay meaningful #PBMreform any longer. Congress must act now.
Tweet card summary image
eric.org
Washington, D.C., November 12, 2025– The ERISA Industry Committee (ERIC) and more than 100 stakeholder groups representing employers, workers, patients, providers, consumers, industry stakeholders,...
0
1
2
@HIVHep
HIV+Hepatitis Policy Institute
1 day
.@Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: https://t.co/KxAqxfcAMr
0
0
0
@DrugChannels
Adam J. Fein
2 days
𝐃𝐚𝐲 𝐨𝐟 𝐑𝐞𝐜𝐤𝐨𝐧𝐢𝐧𝐠 𝐟𝐨𝐫 𝐒𝐡𝐚𝐝𝐲 𝐀𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐬? A powerful @CNBC exposé reveals how shady alternative funding programs (#AFPs) are skirting FDA regulations and guidance by using "unverified suppliers" and "potentially
Tweet card summary image
cnbc.com
AFPs promise to connect patients with more-affordable options for accessing specialty medications that often come at very high costs. There's a major catch.
0
4
8
@HIVHep
HIV+Hepatitis Policy Institute
2 days
Thank you CNBC for exposing these schemes: Cheaper medicines, free beach trips: U.S. health plans tap prescriptions that feds say are illegal
Tweet card summary image
cnbc.com
AFPs promise to connect patients with more-affordable options for accessing specialty medications that often come at very high costs. There's a major catch.
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
4 days
.@Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: https://t.co/KxAqxfcAMr
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
4 days
.@SecretaryLCD must issue a long-promised rule that would end drug middlemen scheme that allows them to classify drugs as "non-Essential Health Benefits" to extract billions of dollars of copay assistance meant for patients for themselves: https://t.co/lCELoJwt2B
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
5 days
.@Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: https://t.co/KxAqxfcAMr
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
6 days
.@Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: https://t.co/KxAqxfcAMr
0
0
1
@HIVHep
HIV+Hepatitis Policy Institute
6 days
.@HIVHep & 63 other #HIV groups wrote to @CVSHealth to urge them to reconsider their decision not to cover @CDCgov recommended new twice-yearly #PrEP injectable Yeztugo. Zero-cost PrEP coverage is both required by law & a public health imperative: https://t.co/rx5zGjrMwN
0
0
0
@Hep_Alliance
World Hepatitis Alliance
7 days
There's no time to waste. Get tested for hepatitis this #HepTestWeek! https://t.co/wUEYKZd4eR
0
3
6
@HIVHep
HIV+Hepatitis Policy Institute
7 days
.@Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: https://t.co/KxAqxfcAMr
0
0
2
@HIVHep
HIV+Hepatitis Policy Institute
8 days
Two Years After Court Victory, Patients Still Saddled with Unaffordable Drug Costs--Government Must Clarify Copay Assistance Counts Towards Patient Cost-Sharing : https://t.co/beXsufKy2Z
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
8 days
Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: https://t.co/KxAqxfcAMr
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
11 days
House Republicans Go Way Beyond President’s Budget by Ending all HIV Prevention & Slash AIDS Care by 20%—Hepatitis Prevention Increased by $10 million: https://t.co/vscaERqA7g
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
12 days
Cuts to #HIV Prevention and Treatment Funding: https://t.co/dNRNDfexuk
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
13 days
In @Benefits_Pro, @HIVHep urges @SecretaryLCD to stop drug middlemen profiting by classifying #Rx as "non-Essential Health Benefits" to extract billions of dollars of #copayassistance meant for #patients for themselves: https://t.co/hwk874z2Wb
0
0
0
@HIVHep
HIV+Hepatitis Policy Institute
14 days
We filed an amicus brief in support of Iowa’s law that requires #copayassistance to count for #Rx’s in #ACA & employer plans. #PBMs contend it is unlawful under ERISA; we explain to the 8th Circuit Court of Appeals why it is not: https://t.co/m7Ls5OCxPz #allcopayscount
0
0
0